Signal transducers and activators of transcription (STATs) are latent cytoplasmic transcription factors that were first identified as mediators of cellular responses to interferons (reviewed in references 12, 16 and 35). Signaling induced by the interaction of interferons and other cytokines with their cognate receptors is initiated by a cascade of events, including receptor aggregation and activation of Janus protein tyrosine kinases (JAKs) associated with the receptors. Subsequently, STAT proteins are recruited to the receptor-JAK complexes and activated by tyrosine phosphorylation, which promotes the formation of homodimers or heterodimers of STAT family members. Activated STATs, in turn, translocate to the nucleus and bind to specific DNA response elements that regulate gene expression. There are at least seven genes in the mammalian genome known to encode different STAT family members, which are activated in various combinations in response to stimulation by numerous cytokines (12, 16, 35) .
Signal transducers and activators of transcription (STATs) are latent cytoplasmic transcription factors that were first identified as mediators of cellular responses to interferons (reviewed in references 12, 16 and 35) . Signaling induced by the interaction of interferons and other cytokines with their cognate receptors is initiated by a cascade of events, including receptor aggregation and activation of Janus protein tyrosine kinases (JAKs) associated with the receptors. Subsequently, STAT proteins are recruited to the receptor-JAK complexes and activated by tyrosine phosphorylation, which promotes the formation of homodimers or heterodimers of STAT family members. Activated STATs, in turn, translocate to the nucleus and bind to specific DNA response elements that regulate gene expression. There are at least seven genes in the mammalian genome known to encode different STAT family members, which are activated in various combinations in response to stimulation by numerous cytokines (12, 16, 35) .
It has become evident that, in addition to cytokines, mitogenic growth factors, such as platelet-derived growth factor and epidermal growth factor, also induce STAT signaling, particularly Stat1, Stat3, and Stat5 (21, 35) . An emerging concept is that normal signaling by STAT proteins is involved in control of diverse biological processes regulated by cytokines and growth factors, including cell differentiation, proliferation, development, and apoptosis (2, 4, 10, 13, 19, 20, 22, 23, 26, 29, 31, 37, 39, 40, 50) . Increasingly, evidence that indicates an association between abnormal activation of STAT signaling and oncogenesis has also been accumulating. For example, we and other investigators have demonstrated constitutive activation of Stat1, Stat3, Stat5, and Stat6 in cells transformed by Src, Abl, and various other oncoproteins and tumor viruses (7, 8, 11, 14, 24, 25, 47, 51) . In the context of human cancer, there is a high frequency of activation of Stat1, Stat3, and Stat5 in breast carcinoma cells (14, 32, 42) and in lymphoid malignancies, including lymphomas and leukemias (15, 43, 49) . Although these findings suggest a role for STAT signaling in cell transformation as well as in human cancer, direct evidence for the obligatory requirement of STAT signaling in oncogenesis has not been reported previously.
Because transformation of mammalian fibroblasts by viral Src (v-Src) specifically induces constitutive activation of one STAT family member, Stat3, this system is ideal for investigating the role of Stat3 signaling in oncogenesis (7, 47) . The embryonic lethality of targeted disruption of the Stat3 gene (39) , however, precludes generation of viable Stat3-deficient mouse models for these studies. An alternative approach for disrupting Stat3 function is to make use of Stat3 dominant negative proteins that interfere with Stat3 signaling. One such variant of Stat3, known as Stat3␤, has been shown to block Stat3 function in response to interleukin 5 (IL-5) stimulation (5) . Stat3␤ is a naturally occurring splice variant with a dele-tion in the C-terminal portion that harbors the transcriptional activation domain and the Ser-727 residue, phosphorylation of which is required for efficient transcriptional activation (44, 45) . As a result of this C-terminal deletion, dimers formed with human Stat3␤ lack transcriptional activity (5) . In some studies, however, mouse Stat3␤ has been shown to activate the promoters of certain genes in a cell type-dependent manner (33, 34) , suggesting that the dominant negative effect of Stat3␤ may be cell type specific.
To investigate Stat3-mediated gene regulation by v-Src and the role of Stat3 in oncogenesis, we disrupted Stat3 signaling by using human Stat3␤. We report that in NIH 3T3 fibroblasts transiently expressing luciferase reporter constructs, v-Src induced Stat3-specific transcriptional activation. As a potent dominant negative modulator of Stat3-mediated signaling, Stat3␤ effectively blocked Stat3-specific gene expression induced by v-Src in these cells. Furthermore, cotransfection of expression vectors encoding Stat3␤ and v-Src suppressed cell transformation of NIH 3T3 fibroblasts, and stable cell lines overexpressing Stat3␤ were found to be resistant to transformation by v-Src. Our findings establish that activation of Stat3 by v-Src induces specific gene regulation and provide evidence for the requirement of Stat3 signaling in cell transformation by the Src oncoprotein.
MATERIALS AND METHODS

Construction of plasmids.
An annealed oligonucleotide corresponding to the Ϫ35 to ϩ11 region (relative to the transcriptional start site at ϩ1) of the herpes simplex virus thymidine kinase (TK) promoter was cloned between the KpnI and BglII sites of the basic luciferase reporter pLuc (pGL2; Promega) to construct pLucTK (see Fig. 1 for structures of constructs). The Stat3 reporter pLucTKS3 was constructed from pLucTK by inserting seven copies of an annealed oligonucleotide corresponding to a Stat3-specific binding site from the human C-reactive protein (CRP) gene (48) , called the CRP acute-phase response element (cAPRE) (nucleotides Ϫ123 to Ϫ85), into the SmaI site upstream of the TK minimal promoter. Another reporter, pLucTKSIE, contains two copies of an annealed oligonucleotide corresponding to a high-affinity mutant of the c-fos sis-inducible element (hSIE [mutant m67]) (41) inserted into the SmaI site of pLucTK. To construct pLucCRP, the authentic CRP promoter (nucleotides Ϫ123 to ϩ3) was excised from plasmid Ϫ123/ϩ3CRP-CAT (48) (a generous gift from D. Samols) by BamHI-XhoI restriction digestion, blunt-ended with Klenow, and inserted into the SmaI site of pLuc. The human Stat3␤ expression vector pSG5hStat3␤ is driven by the simian virus 40 promoter contained in pSG5 (Stratagene) and has been previously described (5) . The Stat3 expression vector pVRStat3 was constructed by excising the mouse Stat3 cDNA from pBSStat3 by EcoRI and DraIII digestion, blunt-ending with T4 DNA polymerase, and cloning into a vector driven by the cytomegalovirus immediate early gene promoter (2a, 50) . The reporter pLucSRE, which contains a serum response element (SRE) in the context of the c-fos promoter driving luciferase expression, as well as the N17-Ras and NT-Raf vectors have been described previously (30, 46) . Expression vectors for v-Src, pMvSrc (17) , and oncogenically activated c-H-Ras have been described previously (28) .
Cell culture and transfections. NIH 3T3 fibroblasts were grown in Dulbecco's modified Eagle's medium (DMEM) containing 5% iron-supplemented bovine calf serum (BCS). Transfections were carried out by the standard calcium phosphate method (9) . NIH 3T3 fibroblasts were seeded at 5 ϫ 10 5 cells/100-mmdiameter plate in DMEM plus 5% BCS at 18 to 24 h prior to transfection. Total DNA for transfections was typically 20 g per plate, including 4 g of luciferase reporter construct (pLucTK, pLucTKS3, pLucCRP, pLucTKSIE, or pLucSRE), 0.2 g of ␤-galactosidase (␤-Gal) internal control vector, and the amounts of expression vector indicated in Results. Transfection was terminated 15 h later by aspirating the medium, washing the cells with 1ϫ phosphate-buffered saline (PBS), and adding fresh DMEM. Where gamma interferon (IFN-␥) was present, it was added 5 h prior to harvest of transfected cells.
Preparation of cytosolic and nuclear extracts. For transient expression assays, cytosolic extracts were prepared from cells at 48 h posttransfection. Briefly, after two washes with 1ϫ PBS and equilibration for 5 min with 0.5 ml of PBS-0.5 mM EDTA, cells were scraped off of the dishes and the cell pellet was obtained by centrifugation (4,500 ϫ g, 2 min, 4°C). Cells were resuspended in 0.4 ml of low-salt HEPES buffer (10 mM HEPES [pH 7.8], 10 mM KCl, 0.1 mM EGTA, 0.1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 1 mM dithiothreitol) for 15 min, lysed by the addition of 20 l of 10% Nonidet P-40, and centrifuged (10,000 ϫ g, 30 s, 4°C) to obtain the cytosolic supernatant, which was used for luciferase assays (Promega) with a luminometer and for ␤-Gal activity detection by colorimetric assay at A 570 . As an internal control for transfection efficiency, results were normalized to ␤-Gal activity. For electrophoretic mobility shift assays (EMSA), nuclear extracts were prepared from transiently transfected NIH 3T3 cells and volumes containing equal amounts of total protein were incubated with 32 P-labeled hSIE oligonucleotide probe, as previously reported (47) . Supershift assays were performed by using rabbit polyclonal antibodies against the C-terminal amino acid residues (750 to 769) of full-length Stat3 that are absent in Stat3␤ (Santa Cruz Biotechnology).
Western blot analysis. Whole-cell lysates were prepared in boiling sodium dodecyl sulfate (SDS) sample buffer in order to extract total Stat3 proteins from the cytoplasm and nucleus. Equivalent amounts of total cellular protein were electrophoresed on an SDS-7.5% polyacrylamide gel and transferred to a nitrocellulose membrane. Probing of nitrocellulose membranes with primary antibodies and detection of horseradish peroxidase-conjugated secondary antibodies by enhanced chemiluminesence (Amersham) were performed as previously described (14, 47) . Probes used were rabbit polyclonal antibodies against the Stat3 C-terminal amino acids that are specific for full-length Stat3 (Santa Cruz Biotechnology) or mouse monoclonal antibody against the Stat3 N-terminal amino acid residues (1 to 178) that recognizes both full-length Stat3 and Stat3␤ (Transduction Laboratories).
Focus formation assays. NIH 3T3 fibroblasts were transfected as described above and then harvested by trypsinization at 48 h posttransfection. Cytosolic extracts were prepared from 25% of the transfected cells to measure ␤-Gal activity, which was used for determination of transfection efficiency. The remaining 75% of the cells were seeded into new dishes and fed 1ϫ DMEM every 3 days. Foci were counted at 16 or 21 days posttransfection by using phase-contrast microscopy.
RESULTS
Stat3-mediated gene regulation is induced by Src.
We previously demonstrated that Stat3 is constitutively activated in Src-transformed fibroblasts, as measured by enhanced tyrosine phosphorylation and DNA-binding activity of Stat3 (47) . To determine whether Stat3 activation by Src could lead to regulation of gene expression, we transiently transfected NIH 3T3 cells with v-Src expression vector and a reporter construct, pLucTKS3 (Fig. 1B) , containing multimerized Stat3-specific binding sites inserted upstream of a TK minimal promoter. This Stat3-specific binding site, which is derived from the human CRP gene and is called cAPRE here, contains the core sequence TTCCCGAA (36, 48) . Assays for luciferase reporter gene expression ( Fig. 2A) show dose-dependent gene induction, up to 15-fold over basal levels, mediated through activation of endogenous cellular Stat3 by increasing amounts of transfected v-Src expression vector. To confirm that this gene induction is dependent on Stat3, we used an expression vector encoding the Stat3 splice variant, Stat3␤ ( Specificity of Stat3-mediated gene regulation. An authentic promoter construct, pLucCRP (Fig. 1B) , harboring cAPRE embedded in the natural context of the CRP gene's promoter (48) , was used to confirm the results obtained with the chimeric pLucTKS3 reporter. Figure 4A shows that v-Src induces expression from pLucCRP and that Stat3␤ functions as a dominant negative modulator of transcription from this promoter, in agreement with the results presented above. As a control, Fig. 4B shows that Stat3␤ overexpression has no effect on the ability of v-Src to induce another reporter construct, pLucSRE (Fig. 1B) , containing the c-fos SRE that is dependent on Ras and Raf-1 signaling for activation (46) . In similar experiments with 20 g of Stat3␤ vector and 200 ng of v-Src vector, the same conditions used in subsequent focus formation assays (see below), there was no effect of Stat3␤ on the ability of Src to induce pLucSRE expression (data not shown). These results demonstrate that Stat3␤ acts through Stat3-binding sites and that Stat3␤ overexpression does not nonspecifically inhibit vSrc function or Stat3-independent signaling pathways leading to SRE induction.
To further characterize the specificity of Src-induced STAT signaling and Stat3␤ function, we used a reporter construct based on the c-fos SIE inserted upstream of the TK promoter. This reporter, pLucTKSIE (Fig. 1B) , contains a high-affinity mutant of the SIE (hSIE) that binds both Stat1 and Stat3 (41, 47) . Figure 5A shows that expression from pLucTKSIE was induced by v-Src, which activates Stat3 but not Stat1 (47) , and to a lesser extent by IFN-␥, which activates Stat1 but not Stat3 (4, 47) . In both cases, gene induction was blocked by expression of Stat3␤, indicating that Stat3␤ can disrupt Stat1 and Stat3 signaling. For comparison of the specificity of the various reporter constructs for Stat1 and Stat3, pLucTKS3, pLucCRP, and pLucTKSIE were activated by either v-Src or IFN-␥. Results shown in Fig. 5B demonstrate that the pLucTKS3 and pLucCRP constructs, both of which harbor cAPRE, are induced specifically by v-Src and not by IFN-␥. This finding confirms that cAPRE responds only to Stat3 signaling and not to Stat1 signaling. Together, our results demonstrate that activation of endogenous cellular Stat3 signaling by v-Src leads to Stat3-specific induction of gene expression, which is disrupted in a dominant-negative manner by Stat3␤.
Induction of Stat3 and Stat3␤ DNA-binding activity by Src. Because Stat3␤ retains an intact DNA-binding domain as well as the SH2 domain and tyrosine required for dimerization, activation of Stat3␤ by v-Src is predicted to induce dimerization and DNA binding. To measure DNA-binding activities, we prepared nuclear extracts from transiently transfected NIH 3T3 cells and performed EMSA with the 32 P-labeled SIE probe that binds both Stat1 and Stat3 with high affinity. Consistent with earlier studies of fibroblasts stably transformed by v-Src (47), Fig. 6A (lanes 1, 2, and 11 to 15) shows that specific DNA-binding activity of endogenous Stat3, but not Stat1, is induced in an Src-dependent manner in transiently transfected NIH 3T3 cells. Moreover, the Src-induced levels of specific DNA-binding activity detected in transiently transfected cells overexpressing Stat3 or Stat3␤ are greater than 10-fold higher than that of cells containing only endogenous Stat3 ( (5) . By supershift analysis with an antibody that recognizes a Cterminal epitope present in full-length Stat3 but not in Stat3␤, we confirmed that activation of Stat3 or Stat3␤ by v-Src induces mostly homodimers when either one is overexpressed alone (Fig. 6B, lanes 1 to 10) and predominantly Stat3-Stat3␤ heterodimers when both proteins are overexpressed together (lanes 11 to 16). Combined with our results presented above, these data suggest that Stat3␤ disrupts Stat3-specific gene regulation by binding to Stat3 response elements as either a homodimer or a heterodimer and preventing transcriptional activation.
Cotransfection of Stat3␤ vector blocks Src transformation. To investigate the role of Stat3 signaling in cell transformation, we tested the effect of Stat3␤ on transformation of NIH 3T3 cells by v-Src. As a sensitive and quantitative measure of cell transformation by v-Src, we used a focus formation assay, which in the case of v-Src correlates very well with growth in soft agar and tumorigenesis (18) . Focus formation assays were performed by using cells transfected with expression vectors for v-Src alone or v-Src together with Stat3␤ (Fig. 7A) . Results show that Stat3␤ consistently inhibited Src-induced focus formation by 50% with small amounts (2 g) of Stat3␤ expression vector, with greater than 80% inhibition observed in cotransfections with larger amounts (20 g) of Stat3␤ expression vector. As a control, cotransfection of empty vector alone did not significantly affect focus formation by v-Src, whereas expression of Stat3␤ alone resulted in levels of focus formation comparable to the background of spontaneous transformation. For comparison with v-Src, the effect of Stat3␤ overexpression on focus formation induced by the activated c-H-Ras oncoprotein, which does not activate Stat3 signaling (14) , was also examined. Stat3␤ overexpression had either no effect (at 2 g of vector) or much-less-pronounced effects (at 20 g of vector) on Ras-induced transformation compared to Src-induced transformation (compare Fig. 7A and B) . These results indicate that Stat3␤ inhibits transformation by Src to a significantly greater extent than it does transformation by Ras.
Cell lines stably overexpressing Stat3␤ are resistant to Src transformation. To confirm the results obtained in the cotransfection experiments described above, and to exclude a possible toxic effect of Stat3␤ overexpression on cell viability, a different approach was taken with cell lines stably overexpressing Stat3␤. Following transfection with Stat3␤ expression vector, G418-resistant colonies were selected, expanded, and further characterized. Western blot analysis with antibodies directed against the N-terminal portion of Stat3 identified three independent clones that stably overexpressed Stat3␤ compared to control NIH 3T3 cells (Fig. 8A) . Transient transfection of these cells with pLucTKS3 reporter together with v-Src vector confirmed that Stat3-mediated signaling was abrogated by Stat3␤ overexpression, while Stat3-independent signaling leading to pLucSRE induction was not affected (Fig. 8B ). In agreement with the results presented in Fig. 2 to 4 , these results indicate that Stat3␤ specifically disrupts Stat3 signaling without impairing v-Src function or other signaling pathways. These findings further demonstrate that cells which stably overexpress Stat3␤ and are deficient in Stat3-mediated signaling remain viable and proliferate. To assess whether these Stat3␤ overexpressing clones could be transformed by Src, focus formation assays were performed following transfection with v-Src expression vector. Results presented in Fig. 9 show that all three Stat3␤-overexpressing clones were refractory to Src-induced cell transformation, with up to 90% inhibition of focus formation. Together, the data shown in Fig. 7 to 9 demonstrate that overexpression of Stat3␤ blocks cell transformation by v-Src, presumably by disrupting Stat3-dependent regulation of the cellular gene expression that is required for v-Src transformation.
DISCUSSION
The initial discoveries of STAT proteins as mediators of intracellular signaling in response to cytokines and growth factors have launched an intensive investigation into the diverse biological functions of STATs (12, 16, 21) . Activation of STAT signaling pathways, including Stat3, has been increasingly associated with cell transformation and human cancer (7, 11, 14, 15, 24, 25, 32, 42, 43, 47, 49) . Cell transformation by v-Src is an ideal system for evaluating the role of Stat3 in oncogenesis because Stat3 is constitutively activated in mammalian fibroblasts stably transformed by v-Src (7, 47) , suggesting a requirement for continuous signaling through Stat3 in order to maintain transformation. Moreover, we have determined that Stat3 is the predominant STAT family member activated in Src-transformed NIH 3T3 cells, with very little or no detectable activation of other STATs (14, 47) , simplifying the analysis of Stat3's role without the complexity of signaling by other STAT family members. To evaluate the role of Stat3 signaling in Src transformation, it was important to first estab- lish that activation of Stat3 by v-Src leads to regulation of specific gene expression which could be disrupted in a dominant-negative manner by Stat3␤. Our results demonstrate that activation of endogenous cellular Stat3 by the v-Src oncoprotein induces Stat3-mediated gene regulation that is specifically abrogated by overexpression of Stat3␤ in NIH 3T3 cells. The findings reported here establish the transcriptional potential of the frequently observed activation of Stat3 in transformed cells and provide evidence that this Stat3 signaling participates in oncogenesis. Because Stat3 is a constitutively activated transcription factor in the context of oncogenesis, these findings further imply a permanent alteration in the genetic program that contributes to oncogenesis of transformed cells harboring activated Stat3.
While the precise mechanism of Stat3 activation by Src is not completely defined, it has been shown that v-Src associates in a complex with Stat3 (7), consistent with the possibility that v-Src directly phosphorylates and activates Stat3. Other studies have provided evidence that JAK family kinases are constitutively activated in Src-transformed fibroblasts, suggesting that v-Src may indirectly activate Stat3 through JAKs (6). These two mechanisms are not mutually exclusive, and it is possible that both contribute to activation of Stat3 signaling by v-Src. In addition, we analyzed the interactions of Stat3 and Stat3␤ with each other to explore the mechanism by which overexpression of Stat3␤ could disrupt Stat3 signaling activated by Src. We detected DNA-binding activity by overexpressed Stat3␤ homodimers and Stat3-Stat3␤ heterodimers in nuclear extracts prepared from cells transiently transfected with v-Src, consistent with two possible mechanisms. One potential mechanism is the occupation of Stat3 binding sites by Stat3␤ homodimers, thereby titrating sites available for binding Stat3 homodimers. On the other hand, another possibility is that Stat3␤ could form heterodimers with Stat3 which may be transactivation deficient. Either or both of these mechanisms may contribute to the disruption of Stat3 signaling in NIH 3T3 cells under conditions in which Stat3 is constitutively activated by v-Src.
At the amino acid level, Stat3␤ is identical to full-length Stat3 for most of the protein but diverges at the carboxyl terminus with an internal deletion in the transactivation domain (5, 34) . In the case of mouse Stat3, 55 amino acids are replaced by 7 different residues in Stat3␤ (34) 
in human Stat3␤
). Phosphorylation of Ser-727 in full-length Stat3 is not required for DNA binding (44) , although it is required for efficient transcriptional activation (45) . However, apparently conflicting reports in the literature regarding the transactivation potential of Stat3␤ underscore the complexity of STAT signal transduction pathways. While an earlier report showed that coexpression of mouse Stat3␤ together with c-Jun transactivates an AP-1-dependent promoter (34), recent evidence demonstrates that mouse Stat3␤ acts as a transactivator or dominant negative modulator of transcription in a cell-typespecific manner (33) . Although the basis for the variable transactivation potentials of Stat3␤ is unknown, it may involve interactions of Stat3␤ with other cell-type-specific transcription factors or coactivators. It is also possible that the structural differences between mouse and human Stat3␤ in the C-terminal portion or elsewhere account for the different transactivation potentials that have been observed (5, 34) .
Despite being one of the most well characterized oncoproteins, the molecular mechanisms by which v-Src subverts normal cellular signaling pathways and transforms cells are not fully defined (1, 38) . The present data demonstrate that activation of Stat3 signaling is required for cell transformation by the v-Src oncoprotein, suggesting that constitutive activation of Stat3 is one of the cellular signaling pathways that participates in maintenance of transformation by v-Src. Given the myriad changes that accompany cell transformation (18) , it is probable that activation of Stat3 signaling is not sufficient by itself to induce cell transformation and that other signaling pathways are also required for transformation by v-Src. At the same time, it is unlikely that Stat3 is involved in transformation by all oncoproteins, since cell transformation mediated by activated c-H-Ras was not significantly inhibited by coexpression of Stat3␤. In addition, because we have been able to generate stable cell lines overexpressing Stat3␤, these results demonstrate that enforced overexpression of Stat3␤ does not severely impair normal cell function or have toxic effects on cell viability. Using a panel of various Stat3 dominant negative mutants and different assays of cell transformation, Bromberg et al. have arrived independently at similar conclusions (3). Together, these findings provide the first direct evidence that, in addition to their signaling functions in normal cells, STATs also participate in oncogenesis. Because activation of Stat3 is associated with human tumors, including breast carcinomas and various lymphoid malignancies (14, 15, 32, 42, 43, 49) , our findings further suggest an important role for Stat3 signaling in the development of these cancers.
The biological mechanism by which Stat3 contributes to oncogenesis remains to be determined. We speculate that Stat3 signaling may contribute to transformation induced by v-Src in NIH 3T3 cells through one of two likely biological mechanisms. One possible mechanism is that constitutive activation of Stat3 signaling may directly stimulate cell proliferation. This possibility is consistent with the finding that numerous growth factors, such as platelet-derived growth factor and epidermal growth factor, activate signaling by STATs, including Stat3 (22, 31, 40, 50) . In addition, gene knockout studies have demonstrated a requirement for Stat4 and Stat6 signaling in mitogenic responses to cytokine stimulation of immune cells (19, 20) . Alternatively, Stat3 may contribute to cell transformation by preventing apoptosis, thereby indirectly increasing cell numbers. This possibility is supported by the finding that activation of Stat3 is required for the anti-apoptosis response to IL-6 stimulation in a murine myeloid cell line (13) . Since Stat3 signaling is implicated in control of cell differentiation, proliferation, and apoptosis (10, 13, 27, 39) , the biological consequences of constitutive Stat3 activation are likely to be complex and dependent on the specific cell type. Nevertheless, the demonstration that Stat3 is one of the critical signaling pathways required for cell transformation by v-Src implies the existence of Stat3-regulated genes that participate in oncogenesis. Thus, identification and characterization of the nuclear genes regulated by Stat3 should provide new insights into the specific events leading to the loss of normal cell growth control and the process of malignant transformation. Values are means plus standard deviations of three independent transfections, except in the case of Stat3␤13, which was tested once.
